Concepedia

Lingjing Lu

LL

Statistics

Publications

4

Citations

153

H-Index

4

Active since

2020

Affiliations

Guangzhou Medical University(Current)

First Affiliated Hospital of Guangzhou Medical University

First Affiliated Hospital of Guangzhou University of Chinese Medicine

Second Affiliated Hospital of Guangzhou Medical University

First Affiliated Hospital of Heilongjiang University of Chinese Medicine

Lingjing Lu is an author at Guangzhou Medical University specializing in endocrinology, nrf2 signaling pathway, and insulin resistance.

Publications per year

2020–2022

4

Publications

4

Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial

Qidan Wen, Min Hu, Maohua Lai et al. · Human Reproduction · 2021 · 95 citations · Full text

Medicine, Endocrinology, Gynecology +13

Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo

Ruqun Zheng, Haoran Shen, Jie Li et al. · Journal of Ethnopharmacology · 2022 · 32 citations

Life Sciences, Pharmacology, Physiology +16

Overactivation of the androgen receptor exacerbates gravid uterine ferroptosis <i>via</i> interaction with and suppression of the NRF2 defense signaling pathway

Min Hu, Yuehui Zhang, Lingjing Lu et al. · FEBS Letters · 2022 · 16 citations

Life Sciences, Biochemistry, Endocrinology +17

A prognosis‑predictive nomogram of ovarian cancer with two immune‑related genes: <em>CDC20B</em> and <em>PNPLA5</em>

Lin Han, Jiamin Wang, Xiaohui Wen et al. · Oncology Letters · 2020 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4